Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PTGX

Protagonist Therapeutics Inc

May 06 • 10:54AM ET

101.32

+2.11 2.13 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AMGN REGN CRSP VRTX NTLA BLUE ARWR EDIT AKRO SGMO

| Held by: IJR VTI VB IWM XBI VBK VXF SPSM IJT IWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.04	Insider Own	5.79%	Shs Outstand	62.58M	Perf Week	2.84%
Market Cap	6.49B	Forward P/E	-	EPS next Y	-0.77	Insider Trans	-8.22%	Shs Float	60.12M	Perf Month	-2.34%
Enterprise Value	5.93B	PEG	-	EPS next Q	2.06	Inst Own	113.59%	Short Float	13.97%	Perf Quarter	21.63%
Income	-130.15M	P/S	140.92	EPS this Y	292.35%	Inst Trans	2.51%	Short Ratio	11.46	Perf Half Y	33.40%
Sales	46.02M	P/B	10.31	EPS next Y	-119.52%	ROA	-18.37%	Short Interest	8.40M	Perf YTD	16.00%
Book/sh	9.82	P/C	11.43	EPS next 5Y	-	ROE	-20.18%	52W High	107.84 -6.05%	Perf Year	141.18%
Cash/sh	8.86	P/FCF	115.64	EPS past 3/5Y	7.63% -1.26%	ROIC	-20.90%	52W Low	41.28 145.41%	Perf 3Y	308.38%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.07% 9.96%	Gross Margin	97.22%	Volatility	2.91% 3.95%	Perf 5Y	261.59%
Dividend TTM	-	EV/Sales	128.82	EPS Y/Y TTM	-145.57%	Oper. Margin	-343.63%	ATR (14)	4.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	12.71	Sales Y/Y TTM	-89.41%	Profit Margin	-282.83%	RSI (14)	51.76	Recom	1.23
Dividend Gr. 3/5Y	- -	Current Ratio	12.71	EPS Q/Q	-134.96%	SMA20	-0.45%	Beta	1.89	Target Price	115.31
Payout	-	Debt/Eq	0.02	Sales Q/Q	-95.64%	SMA50	2.09%	Rel Volume	0.82	Prev Close	99.21
Employees	132	LT Debt/Eq	0.01	Earnings	May 05 AMC	SMA200	25.98%	Avg Volume	732.56K	Price	101.32
IPO	Aug 11, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	109.99% 381.68%	Trades		Volume	153,025	Change	2.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)